Blood Types and Pregnancy: What’s Really Safe?

By James Rodriguez · March 3, 2025

Why This Question Matters More Than You Think — And Why the Answer Isn’t What You’ve Heard

If you’ve ever searched what blood types can't have kids together, you’re not alone — and your anxiety is completely understandable. Millions of couples discover their blood types only after conception, then panic over viral claims that certain combinations ‘can’t safely conceive’ or ‘will cause miscarriage.’ The truth? No blood type pairing prevents conception or makes having children biologically impossible. But some combinations — particularly involving Rh factor mismatch — carry well-understood, highly preventable risks for the baby during pregnancy. What matters isn’t whether you ‘can’t have kids together,’ but whether you know when, how, and with what medical support to optimize outcomes. And that knowledge starts right here — grounded in American College of Obstetricians and Gynecologists (ACOG) guidelines and decades of clinical success.

Debunking the Biggest Myth: Blood Types Don’t Determine Fertility or ‘Compatibility’

Let’s start with what blood typing was never designed to do: predict reproductive viability. Your ABO group (A, B, AB, or O) and Rh factor (+ or −) are inherited genetic traits that determine red blood cell surface antigens — nothing more. They play no role in sperm-egg binding, implantation, hormonal signaling, or uterine receptivity. As Dr. Elena Ramirez, a maternal-fetal medicine specialist at Johns Hopkins and co-author of ACOG’s 2023 Rh Incompatibility Practice Bulletin, confirms: ‘There is zero biological mechanism by which blood type prevents conception. If a couple is struggling to conceive, blood type is never the first — or even the hundredth — thing we investigate.’

So where did the fear originate? Largely from historical confusion around hemolytic disease of the fetus and newborn (HDFN), a rare but serious condition caused when maternal antibodies attack fetal red blood cells. Before modern interventions, HDFN contributed to stillbirths and severe neonatal jaundice — leading to oversimplified, alarming narratives like ‘O mom + A dad = danger.’ Today, HDFN is preventable in >99% of at-risk pregnancies — but only if clinicians and patients understand which combinations require monitoring, and why others don’t.

Rh Incompatibility: The Real (But Manageable) Risk Factor

The most clinically significant blood-type-related pregnancy risk involves Rh factor mismatch: when an Rh-negative mother carries an Rh-positive baby. This scenario occurs in roughly 13% of pregnancies in the U.S. (since ~85% of people are Rh-positive). Here’s how it unfolds:

First pregnancy is usually safe: The mother’s immune system typically isn’t exposed to Rh+ fetal blood until delivery (or miscarriage/abortion/amniocentesis). So antibodies rarely form before birth.
Subsequent Rh+ pregnancies become high-risk: If the mother developed anti-Rh antibodies in a prior pregnancy, those IgG antibodies cross the placenta and destroy fetal red blood cells — causing anemia, heart failure, hydrops fetalis, or stillbirth.
Prevention is simple, proven, and near-perfect: Administering Rh immunoglobulin (RhoGAM®) at 28 weeks gestation and within 72 hours postpartum blocks antibody formation in >99% of cases.

RhoGAM has been used since 1968 and is endorsed by the CDC, ACOG, and WHO. A landmark 2021 study in Obstetrics & Gynecology tracking 42,000 Rh-negative women found zero cases of HDFN in those who received timely RhoGAM — versus a 16% incidence in untreated historical cohorts. Crucially: Rh incompatibility only matters if the mother is Rh-negative. An Rh-positive mother — regardless of her partner’s Rh status — faces no Rh-related risk.

ABO Incompatibility: Mild, Common, and Rarely Dangerous

ABO incompatibility occurs when the mother is type O and the baby inherits type A or B from the father (e.g., O mom + A dad → possible A baby). Unlike Rh, ABO antibodies (IgM) do not cross the placenta — so fetal harm is extremely rare. When it does occur, it’s almost always mild: newborn jaundice requiring phototherapy for 24–48 hours. It’s so common (affecting ~20% of type-O moms) that pediatricians consider it routine — not pathological.

Why the difference? ABO antigens appear on many tissues beyond red blood cells (including gut epithelium), so fetal red cells express fewer A/B antigens early in gestation — reducing target density. Also, maternal anti-A/B antibodies are mostly IgM (too large to cross placenta), whereas anti-Rh antibodies are IgG (small enough to cross freely). As Dr. Marcus Lee, neonatologist and lead author of the AAP’s 2022 Hyperbilirubinemia Clinical Practice Guideline, states: ‘ABO incompatibility is the most frequent cause of jaundice in the first 24 hours of life — but it’s also the least concerning. We treat the bilirubin level, not the blood type.’

Importantly: ABO incompatibility does not increase miscarriage risk, nor does it require prenatal medication, special ultrasounds, or delivery planning changes. It’s managed entirely after birth — if needed at all.

Your Blood Type Compatibility Snapshot: When to Screen, When to Act

Not all combinations warrant equal attention. Below is a clinically validated, ACOG-aligned reference table showing real-world risk levels, required screenings, and intervention thresholds. Note: ‘Low’ risk doesn’t mean ‘no monitoring’ — it means standard prenatal care suffices.

Mother’s Blood Type	Father’s Blood Type	Fetal Risk Profile	Required Screening/Timing	Intervention Threshold
Rh-negative (e.g., O−, A−)	Rh-positive (e.g., O+, A+, AB+)	High — Risk of Rh sensitization & HDFN in subsequent pregnancies	Rh antibody screen at first prenatal visit; repeat at 28 weeks if negative	RhoGAM at 28 weeks + within 72h postpartum (if baby is Rh+)
Rh-negative	Rh-negative (e.g., O−, B−)	None — Baby will be Rh-negative; no antibody production possible	Rh antibody screen at first visit (baseline only)	None — RhoGAM not indicated
Type O (any Rh)	Type A, B, or AB (any Rh)	Low — Possible mild jaundice; no fetal anemia or mortality risk	Bilirubin check at 12–24h post-birth; no prenatal action needed	Phototherapy if bilirubin >15 mg/dL at 24h (per AAP nomogram)
Type A, B, or AB	Any type (including O)	Negligible — No known HDFN risk; no clinical management pathway	None beyond routine prenatal labs	None
Rh-positive (e.g., A+, AB+)	Rh-negative (e.g., O−, B−)	None — Maternal antibodies cannot attack paternal Rh− cells; no fetal risk	None specific to blood type	None

Frequently Asked Questions

Can two O-negative parents have a healthy baby?

Absolutely — and with zero blood-type-related risks. Both parents being O-negative means the baby will also be O-negative. There’s no Rh incompatibility (since baby is Rh-negative), no ABO mismatch (since baby is type O), and no antibody-mediated risk. This is one of the safest combinations from a transfusion and pregnancy standpoint. As noted in the 2023 AABB (American Association of Blood Banks) Standards, O-negative is the universal donor type precisely because it lacks A, B, and Rh antigens — making immune reactions virtually impossible.

Does my partner’s blood type affect my fertility treatments (like IVF)?

No — not in any clinically meaningful way. IVF clinics do not screen or select embryos based on blood type. Preimplantation genetic testing (PGT) focuses on chromosomal abnormalities (e.g., aneuploidy) or monogenic disorders (e.g., cystic fibrosis), never ABO/Rh status. Blood type has no impact on egg quality, embryo development, endometrial receptivity, or implantation success rates. A 2022 meta-analysis in Fertility and Sterility reviewing 18,000 IVF cycles confirmed no association between parental blood groups and live birth rates (p=0.87).

If I’m Rh-negative and had a miscarriage, do I need RhoGAM?

Yes — and this is critically underrecognized. Any event that could expose maternal circulation to Rh+ fetal blood — including miscarriage, abortion, ectopic pregnancy, amniocentesis, CVS, or abdominal trauma — requires RhoGAM within 72 hours to prevent sensitization. According to ACOG Committee Opinion #852, ‘Rh immune globulin should be administered after any pregnancy termination, regardless of gestational age.’ Failure to do so increases the risk of HDFN in future pregnancies by up to 10-fold. If you’re unsure whether you received it, ask your provider for your Rh antibody screen results — a positive result indicates sensitization has already occurred.

Can blood type incompatibility cause infertility or recurrent miscarriage?

No robust evidence supports this. Recurrent pregnancy loss (RPL) is defined as ≥2–3 consecutive losses before 20 weeks. Major causes include parental chromosomal abnormalities, antiphospholipid syndrome, uterine anomalies, endocrine disorders (e.g., thyroid dysfunction, PCOS), and thrombophilias. The American Society for Reproductive Medicine (ASRM) explicitly states in its 2023 RPL guideline: ‘Blood group incompatibility is not a recognized cause of recurrent miscarriage.’ While isolated case reports exist, they lack mechanistic plausibility and fail replication in large cohort studies.

Do I need special prenatal vitamins or diet changes based on blood type?

No — and this is a persistent myth popularized by the unscientific ‘blood type diet.’ Peer-reviewed research, including a 2014 randomized controlled trial in PloS One and a 2021 systematic review in Nutrition Reviews, found no evidence that blood type predicts response to specific nutrients, food sensitivities, or vitamin absorption. All pregnant people need folic acid (400–800 mcg/day), iron (27 mg/day), and vitamin D (600 IU/day) — regardless of ABO or Rh status. Focus on evidence-based nutrition: varied whole foods, adequate protein, omega-3s, and hydration.

Common Myths — And Why They’re Harmful

Myth #1: ‘O-negative and A-positive couples shouldn’t have kids together.’ — This falsely conflates Rh incompatibility (manageable) with absolute incompatibility (nonexistent). An O− mom + A+ dad is a classic Rh-mismatch scenario — but with RhoGAM, outcomes match those of Rh-compatible couples. Spreading this myth causes unnecessary relationship stress and delays in seeking care.
Myth #2: ‘Blood type determines whether you’ll miscarry.’ — Miscarriage affects ~10–20% of known pregnancies, primarily due to chromosomal errors in the embryo (50–70% of cases). Blaming blood type diverts attention from evidence-based evaluation — like karyotyping products of conception or testing for antiphospholipid antibodies — delaying proper diagnosis and treatment.

Take Control With Knowledge — Not Fear

The question what blood types can't have kids together stems from genuine love and protective instinct — but it’s rooted in outdated information. Modern obstetrics has transformed Rh incompatibility from a feared complication into a routinely prevented non-event. Your blood type doesn’t define your family-building journey; your access to accurate information and timely care does. If you’re planning pregnancy or are already expecting, request your blood type and Rh status at your first prenatal visit — and ask specifically: ‘Was my Rh antibody screen checked? Do I need RhoGAM?’ That one question, paired with trusted clinical guidance, is all it takes to ensure your baby’s safety. Next step: Download our free, ACOG-aligned ‘Prenatal Blood Work Checklist’ — it walks you through every lab test, timing window, and what abnormal results truly mean.